{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:34:55Z","timestamp":1648845295165},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12288-019-01075-z","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T06:29:04Z","timestamp":1548916144000},"page":"26-31","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Highlights of Abstracts on Plasma Cell Dyscrasia in the Annual Conference ISHBT (Kochi)"],"prefix":"10.1007","volume":"35","author":[{"given":"Tathagat","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"issue 1 supplem","key":"1075_CR1","first-page":"365","volume":"34","author":"V Shruthi","year":"2018","unstructured":"Shruthi V, Manipadam MT, Geevar T (2018) Looks can be deceptive-anaplastic myeloma mimicking myelodysplastic syndrome (Haematocon 2018-257). Indian J Hematol Blood Transfus 34(issue 1 supplement):365","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"issue 1 supplem","key":"1075_CR2","first-page":"262","volume":"34","author":"A Agarwal","year":"2018","unstructured":"Agarwal A, Singh A, Tanweer N (2018) Plasma cell leukemia with plasmablastic morphology mimicking acute myeloid leukaemia\u2014a rare case report (Haematocon 2018-420). Indian J Hematol Blood Transfus 34(issue 1 supplement):262","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"issue 1 supplem","key":"1075_CR3","first-page":"362","volume":"34","author":"S Monica","year":"2018","unstructured":"Monica S, Khan EM, Basu A (2018) A case of multiple myeloma with plasmablastic morphology\u2014a rare variant (Haematocon 2018-228). Indian J Hematol Blood Transfus 34(issue 1 supplement):362","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1075_CR4","unstructured":"Venkatesan S, Sharma S (2018) Unusual morphological variants of plasma cell neoplasms (Haematocon 2018-294). Indian J Hematol Blood Transfus (issue 1 supplement):366"},{"key":"1075_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2559.2004.01763.x","volume":"44","author":"SS Banerjee","year":"2004","unstructured":"Banerjee SS, Verma S, Shanks JH (2004) Morphological variants of plasma cell tumours. Histopathology 44:2\u20138","journal-title":"Histopathology"},{"issue":"1","key":"1075_CR6","first-page":"43","volume":"4","author":"CJ Manasa Ravath","year":"2017","unstructured":"Manasa Ravath CJ, Kulkarni N, Vinod R (2017) Mott cells\u2014at a glance. Int J Contemp Med Res 4(1):43\u201344","journal-title":"Int J Contemp Med Res"},{"key":"1075_CR7","unstructured":"Kumar K, Ningombam A, Irshad M, Parshuram PP (2018) Mott cells in peripheral blood smear of dengue fever (Haematocon 2018-596). Indian J Hematol Blood Transfus (issue 1 supplement):226"},{"issue":"22","key":"1075_CR8","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1182\/blood.V128.22.5646.5646","volume":"128","author":"P Dhiman","year":"2016","unstructured":"Dhiman P, Goel S, Samal P, Sood N, Sachdev R, Yadav SP, Vaid AK (2016) FISH analysis in multiple myeloma\u2014a retrospective study from India. Blood 128(22):5646","journal-title":"Blood"},{"issue":"issue 1 supplem","key":"1075_CR9","first-page":"374","volume":"34","author":"NB Janet","year":"2018","unstructured":"Janet NB, Devasia AJ, Palle A, Maniapadam MT et al (2018) Multiple myeloma risk stratification by FISH analysis\u2014a single centre experience. (Haematocon 2018-518). Indian J Hematol Blood Transfus 34(issue 1 supplement):374","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1075_CR10","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1182\/blood.V120.21.4983.4983","volume":"120","author":"AG Szabo","year":"2012","unstructured":"Szabo AG, Gang AO, Poulsen TS, Klausen TW, N\u00f8rgaard PH (2012) T(11;14), cyclin D1, CD20 and CD56 in multiple myeloma: a retrospective study of pathologic and clinical associations. Blood 120:4983","journal-title":"Blood"},{"issue":"3","key":"1075_CR11","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.1182\/blood-2002-11-3333","volume":"102","author":"N Robillard","year":"2003","unstructured":"Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ et al (2003) CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood 102(3):10701","journal-title":"Blood"},{"issue":"issue 1 supplem","key":"1075_CR12","first-page":"361","volume":"34","author":"SHA Khan","year":"2018","unstructured":"Khan SHA, Mahesh K, Varghese RG (2018) Expression of Cd 20 and cyclin D1 in bone marrow biopsy of patients with multiple myeloma and its correlation with morphological features. (Haematocon 2018-180). Indian J Hematol Blood Transfus 34(issue 1 supplement):361","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1075_CR13","first-page":"122","volume":"2013","author":"T Hallgrimsdottir","year":"1946","unstructured":"Hallgrimsdottir T, Porwit A, Bj\u00f6rkholm M, Rossmann E, Steingrimsdottir H, Lund SH, Kristinsson SY (1946) Bone marrow fibrosis in patients with multiple myeloma: a new prognostic factor for survival? Blood 2013:122","journal-title":"Blood"},{"issue":"supplement","key":"1075_CR14","first-page":"370","volume":"34","author":"P Murthy","year":"2018","unstructured":"Murthy P, Mahajan S, Singh T (2018) Bone marrow fibrosis in multiple myeloma. (Haematocon 2018-367). Indian J Hematol Blood Transfus 34(supplement):370","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"8","key":"1075_CR15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1055\/s-0031-1297372","volume":"37","author":"A Coppola","year":"2011","unstructured":"Coppola A, Tufano A, Di Capua M, Franchini M (2011) Bleeding and thrombosis in multiple myeloma and related plasma cell disorders. Semin Thromb Hemost 37(8):929\u2013945","journal-title":"Semin Thromb Hemost"},{"issue":"supplement","key":"1075_CR16","first-page":"367","volume":"34","author":"A Purohit","year":"2018","unstructured":"Purohit A, Bohra GK, Bohra HK, Ahari K (2018) Multiple myeloma presenting as bleeding diathesis\u2014an atypical presentation. (Haematocon 2018-321). Indian J Hematol Blood Transfus 34(supplement):367","journal-title":"Indian J Hematol Blood Transfus"},{"key":"1075_CR17","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1182\/blood-2007-03-081018","volume":"111","author":"P Heinz Ludwig","year":"2008","unstructured":"Heinz Ludwig P et al (2008) Myeloma in patients younger than age 50\u00a0years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood 111:4039","journal-title":"Blood"},{"issue":"supplement","key":"1075_CR18","first-page":"371","volume":"34","author":"MSIS Rumi","year":"2018","unstructured":"Rumi MSIS, Chowdhury S, Jahan D, Muquit T, Saleh A (2018) A-29-year young male patient with multiple myeloma. (Haematocon 2018-392). Indian J Hematol Blood Transfus 34(supplement):371","journal-title":"Hematol Blood Transfus"},{"issue":"13","key":"1075_CR19","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N et al (2016) International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol 34(13):1544\u20131557","journal-title":"J Clin Oncol"},{"issue":"suppl_4","key":"1075_CR20","doi-asserted-by":"publisher","first-page":"iv52","DOI":"10.1093\/annonc\/mdx096","volume":"28","author":"P Moreau","year":"2017","unstructured":"Moreau P, San Miguel J, Sonneveld P, Mateos MV, Zamagni E, Avet-Loiseau H, Hajek R, Dimopoulos MA, Ludwig H, Einsele H, Zweegman S, Facon T, Cavo M, Terpos E, Goldschmidt H, Attal M, Buske C, On Behalf of the ESMO Guidelines Committee (2017) Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv52\u2013iv61","journal-title":"Ann Oncol"},{"key":"1075_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","volume":"100","author":"E Terpos","year":"2015","unstructured":"Terpos E, Kleber M, Engelhardt M et al (2015) European myeloma network guidelines for the management of multiple myeloma-related complications. Haematologica 100:1254\u20131266","journal-title":"Haematologica"},{"key":"1075_CR22","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1200\/JCO.2010.30.8791","volume":"28","author":"MA Dimopoulos","year":"2010","unstructured":"Dimopoulos MA, Terpos E, Chanan-Khan A et al (2010) Renal impairment in patients with multiple myeloma: a consensus statement on behalf the International Myeloma Working Group. J Clin Oncol 28:4976\u20134984","journal-title":"J Clin Oncol"},{"key":"1075_CR23","unstructured":"Nath UK, Chetia R. Renal salvage with bortezomib\/cyclophosphamide\/dexamethasone therapy in newly diagnosed multiple myeloma patients with renal insufficiency: a single-center study. (Haematocon 2018-396). Indian J Hematol Blood Transfus 34(supplement):60"},{"issue":"1","key":"1075_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","volume":"91","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV, Kumar S (2016) Multiple myeloma: diagnosis and treatment. Mayo Clin Proc 91(1):101\u2013119","journal-title":"Mayo Clin Proc"},{"key":"1075_CR25","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1038\/leu.2015.274","volume":"29","author":"M Cavo","year":"2015","unstructured":"Cavo M, Pantani L, Pezzi A, Petrucci MT, Patriarca F, Di Raimondo F, Marzocchi G, Galli M, Montefusco V, Zamagni E, Gamberi B, Tacchetti P, Brioli A, Palumbo A, Sonneveld P (2015) Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma. Leukemia 29:2429\u20132431","journal-title":"Leukemia"},{"issue":"supplement","key":"1075_CR26","first-page":"369","volume":"34","author":"NM Kumar","year":"2018","unstructured":"Kumar NM, Kalita PP, Bhattacharya J, Dutta S, Talukdar A, Barman R (2018) Study on prognostic factors and short term outcome of treatment of multiple myeloma patients at a tertiary care hospital. (Haematocon 2018-363). Indian J Hematol Blood Transfus 34(supplement):369","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"supplement","key":"1075_CR27","first-page":"364","volume":"34","author":"AK Jitani","year":"2018","unstructured":"Jitani AK, Dolai TK, Mandal PK, Baul SN et al (2018) Bortezomib-thalidomide-dexamethasone (Vtd) in newly diagnosed multiple myeloma: a real world experience. (Haematocon 2018-242). Indian J Hematol Blood Transfus 34(supplement):364","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"1075_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3906\/sag-1611-97","volume":"48","author":"A Uysal","year":"2018","unstructured":"Uysal A, Akad Soyer N, \u00d6zkan M, \u015eahin F, Vural F, T\u00f6b\u00fc M, Tombulo\u011flu M, Saydam G (2018) Carfilzomib experience in relapsed\/refractory multiple myeloma: a single-center experience. Turk J Med Sci 48(1):80\u201383","journal-title":"Turk J Med Sci"},{"key":"1075_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S1470-2045(17)30578-8","volume":"18","author":"MA Demopoulos","year":"2017","unstructured":"Demopoulos MA, Goldschmidt H, Niesvizky R et al (2017) Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial. Lancet Oncol 18:1327\u20131337","journal-title":"Lancet Oncol"},{"issue":"supplement","key":"1075_CR30","first-page":"372","volume":"34","author":"R Sandal","year":"2018","unstructured":"Sandal R, Jandial A, Mishra K, Lad D et al (2018) Real world experience of generic carfilzomib for relapsed refractory multiple myeloma (Rrmm). (Haematocon 2018-515). Indian J Hematol Blood Transfus 34(supplement):372","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"1075_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3324\/haematol.2017.174573","volume":"103","author":"F Gay","year":"2018","unstructured":"Gay F, Engelhardt M, Terpos E, W\u00e4sch R, Giaccone L et al (2018) From transplant to novel cellular therapies in multiple myeloma: European myeloma network guidelines and future perspectives. Haematologica 103(2):197\u2013211","journal-title":"Haematologica"},{"issue":"supplement","key":"1075_CR32","first-page":"61","volume":"34","author":"Y Uday","year":"2018","unstructured":"Uday Y, Yadav S, Das SR, Kapoor R et al (2018) Multiple myeloma- real world experience of transplantation in multiple myeloma from a tertiary care centre in North India. (Haematocon 2018-573). Indian J Hematol Blood Transfus 34(supplement):61","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"1075_CR33","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3324\/haematol.2017.181339","volume":"103","author":"HW Auner","year":"2018","unstructured":"Auner HW, Iacobelli S, Sbianchi G, Knol-Bout C et al (2018) Melphalan 140\u00a0mg\/m2 or 200\u00a0mg\/m2 for autologous transplantation in myeloma: results from the collaboration to collect autologous transplant outcomes in lymphoma and myeloma (CALM) study. A report by the EBMT chronic malignancies working party. Haematologica 103(3):514\u2013521","journal-title":"Haematologica"},{"key":"1075_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41409-017-0047-7","volume":"53","author":"A Kardduss-Urueta","year":"2018","unstructured":"Kardduss-Urueta A, Gale RP, Gutierrez-Aguirre CH, Herrera-Rojas MA, Murrieta-\u00c1lvarez I, PerezFontalvo R, Ruiz-Delgado GJ, Ruiz-Rojas G, Jaimovich G, Feldman L, Labastida-Mercado N, Endara A, Castro M, Galindo-Becerra S, Cardona-Molina MA, Gomez-Almaguer D, Ruiz-Arg\u00fcelles GJ (2018) Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas. Bone Marrow Transplant 53:457\u2013460","journal-title":"Bone Marrow Transplant"},{"issue":"supplement","key":"1075_CR35","first-page":"63","volume":"34","author":"U Kulkarni","year":"2018","unstructured":"Kulkarni U, Devasia AJ, Korula A, Fouzia NA et al (2018) Use of non-cryopreserved peripheral blood stem cells is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant. (Haematocon 2018-522). Indian J Hematol Blood Transfus 34(supplement):63","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"supplement","key":"1075_CR36","first-page":"375","volume":"34","author":"V Raghavan","year":"2018","unstructured":"Raghavan V, Nair CK, Avaronnan M, Shenoy PK et al (2018) Unmet needs in multiple myeloma patients: experience from a tertiary cancer centre in South India. (Haematocon 2018-532). Indian J Hematol Blood Transfus 34(supplement):375","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"supplement","key":"1075_CR37","first-page":"376","volume":"34","author":"M Avaronnan","year":"2018","unstructured":"Avaronnan M, Raghavan V, Shenoy PK, Sanjeev Kumar PB et al (2018) Health related quality of life in patients with multiple myeloma on novel agents: experience from a tertiary cancer centre in south India. (Haematocon 2018-568). Indian J Hematol Blood Transfus 34(supplement):376","journal-title":"Indian J Hematol Blood Transfus"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-019-01075-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-019-01075-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:21:21Z","timestamp":1580343681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-019-01075-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1007\/s12288-019-01075-z","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"6 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}